4 Ways Anesthesia Shifted in The Age of Covid-19

Full Article Published in OR Today by Steven Eror, CEO of Solo-Dex

WOLF CREEK, MT / ACCESSWIRE / July 15, 2021 / There are four important trends in anesthesia that emerged from the Covid pandemic. His article, “Leading-Edge Anesthesia in the Post Covid Era,” appears in full at ORToday.com

In the article, Mr. Eror observes:

  • Continuous Regional Anesthesia Reduces the Risk of Patient and Operating Staff Infection
  • Continuous Regional Anesthesia Reduces Risk of Oral Opioid Abuse
  • Regional Anesthesia Offers Scheduling Advantages
  • Regional Anesthesia has Innovated to Overcome Technical Challenges

Mr. Eror states, “The awareness that regional anesthesia has innovated surgical and recovery pain management became evident to patients, providers, and payors during the crisis of the pandemic. The lessons learned will support the opportunity to improve the way we provide care.”

He concludes that the use of continuous regional anesthesia is expanding rapidly. Clinicians have developed a much greater appreciation of its ability to manage pain for safer more pleasant surgery and faster recovery. As a company focused upon bringing continuous regional anesthesia into broader use and into the home, Solo-Dex is well-positioned to benefit from these trends.

The Montana High Tech Business Alliance put Solo-Dex on its 2020 list of Montana Companies to Watch, one of 11 firms so honored.

About OR Today

For nearly 20 years, OR Today has provided perioperative and SPD professionals with up-to-date news and information about their profession. The magazine aims to educate readers about new guidelines, techniques, and equipment, as well as practical information for career building, problem-solving and overall well-being.


Solo-Dex is a developer and distributor of medical catheters, founded by leading anesthesiologists to reduce the cost and risk associated with general anesthesia by improving surgical patient recovery times, reducing medical personnel exposure to Covid-19, reducing or eliminating the misuse of opioid-related pain management, and by safely and effectively managing pain before, during and after a procedure. For more information about SOLO-DEX, please log on to www.solo-dex.com

Media Contact:
Janet Vasquez, Public Relations
Solo-Dex Inc.

SOURCE: Solo-Dex Inc.

View source version on accesswire.com:

error: Content is protected !!